SC Filed 2019-06-07 Event — SEC 0001140361-19-010688 →

KIRK RANDAL J → HALOZYME THERAPEUTICS INC HALO

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (6.2 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

26 transactions

1 buys · 19 sales · 6 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

21 filings by this filer

20 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 6.16

13,654,228 shares short · -10.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $54.24M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-08	Torley Helen	director, officer	Option exercise	20,000	$18.41	$368K
2026-10-08	Torley Helen	director, officer	Sale	4,810	$108.18	$520K
2026-10-08	Torley Helen	director, officer	Sale	3,090	$108.91	$337K
2026-10-08	Torley Helen	director, officer	Sale	11,900	$110.00	$1.31M
2026-10-08	Torley Helen	director, officer	Sale	200	$110.51	$22K
2026-10-07	Torley Helen	director, officer	Option exercise	20,000	$18.41	$368K
2026-10-07	Torley Helen	director, officer	Sale	8,600	$111.03	$955K
2026-10-07	Torley Helen	director, officer	Sale	10,300	$111.84	$1.15M
2026-10-07	Torley Helen	director, officer	Sale	900	$112.78	$102K
2026-10-07	Torley Helen	director, officer	Sale	200	$113.69	$23K
2026-10-06	Torley Helen	director, officer	Option exercise	20,000	$18.41	$368K
2026-10-06	Torley Helen	director, officer	Sale	2,300	$107.90	$248K
2026-10-06	Torley Helen	director, officer	Sale	6,000	$109.33	$656K
2026-10-06	Torley Helen	director, officer	Sale	9,920	$109.89	$1.09M
2026-10-06	Torley Helen	director, officer	Sale	1,780	$110.81	$197K
2026-09-11	Torley Helen	director, officer	Option exercise	20,000	$18.41	$368K
2026-09-11	Torley Helen	director, officer	Sale	15,492	$107.15	$1.66M
2026-09-11	Torley Helen	director, officer	Sale	4,508	$107.55	$485K
2026-09-10	Torley Helen	director, officer	Option exercise	20,000	$18.41	$368K
2026-09-10	Torley Helen	director, officer	Sale	14,588	$107.01	$1.56M
2026-09-10	Torley Helen	director, officer	Sale	5,412	$107.58	$582K
2026-09-09	Torley Helen	director, officer	Option exercise	20,000	$18.41	$368K
2026-09-09	Torley Helen	director, officer	Sale	13,304	$107.22	$1.43M
2026-09-09	Torley Helen	director, officer	Sale	6,596	$107.82	$711K
2026-09-09	Torley Helen	director, officer	Sale	100	$108.67	$11K

Showing 25 of 26

Other Filings by KIRK RANDAL J

Filed	Form	Issuer	Stake	Shares
2024-05-03	SC	PRECIGEN, INC. PGEN	—	—	view →
2021-11-24	SC	AquaBounty Technologies, Inc. AQB	—	—	view →
2020-12-21	SC	AquaBounty Technologies, Inc. AQB	—	—	view →
2020-12-21	SC	PRECIGEN, INC. PGEN	—	—	view →
2020-10-08	SC	ORAGENICS INC OGEN	—	—	view →
2020-08-13	SC	PRECIGEN, INC. PGEN	—	—	view →
2020-08-13	SC	AquaBounty Technologies, Inc. AQB	—	—	view →
2020-03-02	SC	ORAGENICS INC OGEN	—	—	view →
2020-02-04	SC	PRECIGEN, INC. PGEN	—	—	view →
2020-01-06	SC	INTREXON CORP PGEN	—	—	view →
2019-09-17	SC	Fibrocell Science, Inc.	—	—	view →
2019-06-10	SC	INTREXON CORP PGEN	—	—	view →
2019-05-28	SC	INTREXON CORP PGEN	—	—	view →
2019-05-15	SC	INTREXON CORP PGEN	—	—	view →
2019-04-03	SC	Synthetic Biologics, Inc. TOVX	—	—	view →
2019-01-15	SC	HISTOGENICS CORP OCGN	—	—	view →
2018-07-06	SC	INTREXON CORP PGEN	—	—	view →
2018-01-22	SC	INTREXON CORP PGEN	—	—	view →
2018-01-19	SC	AquaBounty Technologies, Inc. AQB	—	—	view →
2018-01-02	SC	INTREXON CORP PGEN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →